Nutritional epidemiological studies in cancer prevention: What went wrong, and how to move forwards

European Journal of Cancer Prevention

Volumn 20, Issue 6, 2011, Pages 518-525

  Fortes, Cristina ^a   Boffetta, Paolo ^b,c  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cancer prevention; nutritional epidemiological studies; supplementation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FOLIC ACID; MICRORNA; PYRIDOXINE; RETINOL; SELENIUM; TRACE ELEMENT; ZINC;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; GENETIC POLYMORPHISM; HIGH RISK POPULATION; NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; CHEMOPREVENTION; DIET; EPIDEMIOLOGIC STUDIES; HUMANS; MICRONUTRIENTS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80053647423     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283481e07     Document Type: Review

References (55)

1. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rauthalahti M, et al. (1996). Alpha-tocopherol and beta-carotenes supplements and lung cancer incidences in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88:1560-1570. (Pubitemid 26374509)
2. Ames BN (1999). Micronutrient deficiencies: a major cause of DNA damage. Ann N Y Acad Sci 889:87-106. (Pubitemid 30040429)
3. ATBC Study Group (2003). Incidence of cancer and mortality following a-tocopherol and b-carotene supplementation. A postintervention follow-up. JAMA 290:476-485.
4. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. (1993). Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Natl Cancer Inst 85:1483-1492. (Pubitemid 23269183)
5. Botterweck AA, Van den Brandt PA, Goldbohm RA (2000). Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer 88:737-748. (Pubitemid 30091091)
6. Carman S, Kamangar F, Freedman ND, Wright ME, Dawsey SM, Dixon LB, et al. (2009). Vitamin E intake and risk of esophageal and gastric cancers in the NIH-AARP Diet and Health Study. Int J Cancer 125:165-170.
7. Colditz GA, Sellers TA, Trapido E (2006). Epidemiology-identifying the causes and preventability of cancer? Nat Rev Cancer 6:75-83.
8. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. (2007). Folic acid for the prevention of colorectal adenomas: a randomised clinical trial. JAMA 297:2351-2359. (Pubitemid 46883748)
9. Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE, et al. (1999). Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 86:1783-1792. (Pubitemid 29513048)
10. Cook NR, Le IM, Manson JE, Buring JE, Hennekens CH (2000). Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control 11:617-626. (Pubitemid 30636361)
11. Coppens P, Da Silva MF, Pettman S (2006). European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety. Toxicology 221:59-74. (Pubitemid 43325007)
12. Cui Y, Lu Z, Bai L, Shi Z, Zhao WE, Zhao B (2007). b-Carotene induces apoptosis and up-regulates peroxisome proliferators-activated receptor gamma expression and reactive oxygen species production in MCF-7 cancer cells. Eur J Cancer 43:2590-2601. (Pubitemid 350086930)
13. Davey Smith G, Ebrahim S (2003). 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1-22. (Pubitemid 36503465)
14. Davis CD, Ross SA (2008). Evidence for dietary regulation of microRNA expression in cancer cells. Nutrition Rev 66:477-482.
15. Downs M, Tucker K, Christ-Schmidt H, Wittes J (2010). Some practical problems in implementing randomization. Clin Trials 7:235-245.
16. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF, et al. (2003). Selenium supplementation and secondary prevention of nonmelano-ma skin cancer in a randomized trial. J Natl Cancer Inst 95:1477-1481. (Pubitemid 37279333)
17. Ebbing M, Bønaa HK, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al. (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302:2119-2126.
18. Ebrahim S, Davey Smith GE (2008). Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 123:15-33.
19. Fenech MF (2010). Dietary reference values of individual micronutrients and nutriomes for genome damage prevention: current status and a road map to the future. Am J Clin Nutr 91:1438s-1454s.
20. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, et al. (2009). Folic acid and risk of prostate cancer results from a randomized clinical trial. J Natl Cancer Inst 101:432-35.
21. Fortes C. Carotenoids in cancer prevention. In: Bartoszek A, Baer-Dubowska W, Malejka-Giganti D, editors. Carcinogenic and anticarcinogenic food components. Boca Raton: CRC series; 2005. pp. 283-296.
22. Fortes C, Virgili F (2008). Antioxidant vitamins are not 'just antioxidants': not necessarily harmful when targeted to the right population. Biofactors 33:177-180.
23. Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH (2000). A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study. Arch Dermatol 136:179-184. (Pubitemid 30090756)
24. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Omenn GS, et al. (2004). The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping b-carotene and retinol supplements. J Nat Cancer Inst 96:1743-1750. (Pubitemid 39654568)
25. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al. (1999). Daily sunscreen application and beta-carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 354:723-729. (Pubitemid 29405786)
26. Hamilton IMJ, Gilmore WS, Benzie IFF, Mulholland CW, Strain JJ (2000). Interactions between vitamins C and E in human subjects. Br J Nutr 84: 261-267.
27. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. (2004). The SUVIMAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 64:2335-2342. (Pubitemid 39532244)
28. Hercberg S, Ezzedine K, Guinot C, Preziosi P, Galan P, Bertrais S, et al. (2007). Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137:2098-2105. (Pubitemid 47367272)
29. Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, Touvier M, Favier A, Latino-Martel P, et al. (2010). Incidence of cancer, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and mineral supplements: a postintervention follow-up in the SU.VI MAX study. Int J Cancer 127:1875-1881.
30. Klaunig JE, Kamendulis LM (2004). The role of oxidative stress in carcinogenesis. Ann Rev Pharmacol Toxicol 44:239-267. (Pubitemid 38263841)
31. Klaunig JE, Kamendulis LM, Hocevar BA (2010). Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38:96-109.
32. Kuanrong L, Kaaks R, Linseisen J, Rohrmann S (2010). Consistency of vitamin and/or mineral supplement use and demographic, lifestyle and heath-status predictors: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr 5:1-7.
33. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH (1999). Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 91:2102-2106. (Pubitemid 30019571)
34. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. (2005). Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294:56-65. (Pubitemid 41002839)
35. Li K, Kaaks R, Linseisen J, Rohrmann S (2010). Consistency of vitamin and/or mineral supplement use and demographic, lifestyle and heath-status predictors: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr 5:1-7.
36. Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, et al. (2009). Vitamins C and E and beta-carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 101:14-23.
37. Lippman SM, Klein EA, Goodman PJ, Scott Lucia M, Thompson IM, Ford LG, et al. (2009). Effect of selenium and vitamin E on risk of prostate cancer and other cancers. The selenium and vitamin E cancer prevention trial (SELECT). JAMA 301:39-51.
38. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al.; HOPE, HOPE-TOO Trial Investigators (2005). Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338-1347. (Pubitemid 40381486)
39. Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist M, et al. (2009). Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 18: 2202-2206.
40. Neuhouser ML, Wassertheil-Smoller S, Thomson C, Aragaki A, Anderson GL, Manson JE, et al. (2009). Multivitamin use and risk of cancer and cardiovascular disease in the women's health initiative cohorts. Arch Intern Med 169:294-304.
41. Nitsch D, Molokhia M, Smeeth L, DeStavola BL, Whittaker JC, Leon DA (2006). Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol 163:397-403.
42. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. (1996). Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 88:1550-9150.
43. Pendlenton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, et al. (2008). Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer 8:132.
44. Peters U, Littman AJ, Kristal AR, Patterson RE, Potter JD, White E (2008). Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and Lifestyle (VITAL) study cohort. Cancer Causes Control 19:75-87.
45. Peto R, Doll R, Buckley JD, Sporn MB (1981). Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201-208.
46. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, et al. (2009). Total and cancer mortality after supplementation with vitamins and minerals: follow up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst 101:507-518.
47. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF (2004). Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160:339-349. (Pubitemid 39045265)
48. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macías H, Reyes-Ruiz NI, Estela del Rio-Navarro B, et al. (2004). Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 59:8-10. (Pubitemid 38067964)
49. Törnwall ME, Virtamo J, Korhonen PA, Virtanen MJ, Albanes D, Huttunen JK (2004). Postintervention effect of alpha tocopherol and beta carotene on different strokes: a 6-year follow-up of the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Stroke 35:1908-1913. (Pubitemid 38971874)
50. US Department of Health and Human Services. US Food and Drug Administration. http://www. fda.gov/food/dietarysupplements [last accessed 8 October 2010].
51. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical activity and the prevention of cancer. Washington, DC: American Institute for Cancer Research; 2009.
52. Wright ME, Virtamo J, Hartman AM, Pietinen P, Edwards BK, Taylor PR, et al. (2007). Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial. Cancer 109:891-898. (Pubitemid 46333531)
53. Wright ME, Weinstein SJ, Lawson KA, Albanes D, Subar AF, Dixon LB, et al. (2007). Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 16:1128-1135. (Pubitemid 46984948)
54. Yu W, Sanders BG, Kline K (2003). RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res 63:2483-2491. (Pubitemid 36605187)
55. Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE (2008). Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 300:2012-2021.